Resistance mechanisms in Gram-negative bacteria

Med Intensiva (Engl Ed). 2022 Jul;46(7):392-402. doi: 10.1016/j.medine.2022.05.004. Epub 2022 May 31.

Abstract

Enterobacterales resistant to carbapenems or producing extended-spectrum β-lactamases (ESBL) and non-fermenters resistant to carbapenems present resistance to many of the antimicrobials commonly used in clinical practice, and have been recognized by the World Health Organization as a critical priority for the development of new antimicrobials. In this review, the main mechanisms of resistance of Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii and Stenotrophomonas maltophilia to β-lactams, quinolones, aminoglycosides and polymyxins will be addressed. Updated information will be presented on the importance in resistance of antimicrobial modification mechanisms (including class C or extended-spectrum β-lactamases, carbapenemases and aminoglycoside-modifying enzymes), permeability alterations due to porin or lipopolysaccharide expression disorders, production of active efflux pumps, target alterations or protection, and expression of two-component systems.

Keywords: Acinetobacter baumannii; Antimicrobial agents; Antimicrobianos; Enterobacterales; Enterobacterias; Pseudomonas aeruginosa; Resistance; Resistencia; Stenotrophomonas maltophilia.

Publication types

  • Review

MeSH terms

  • Acinetobacter baumannii*
  • Anti-Bacterial Agents / pharmacology
  • Carbapenems / pharmacology
  • Drug Resistance, Multiple, Bacterial*
  • Gram-Negative Bacteria
  • beta-Lactamases

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • beta-Lactamases